Private & confidential
Dr. Cai Qichun
Chinese name: 蔡绮纯
Chief Physician, Academic Leader of the Oncology Center . Medical Oncology
Dr. Cai Qichun is Director and academic leader of the Oncology Center at Guangdong Clifford Hospital, a chief physician and oncology PhD. She specializes in chemotherapy, targeted therapy and immunotherapy for lymphoma, head and neck cancer, lung cancer and gastrointestinal tumors, and proposed a holistic tumor immunotherapy theory.
Dr. Cai Qichun
20+ years
Oncology clinical practice
30+
Peer-reviewed publications
6+
Provincial-or-above research grants
About Dr. Cai Qichun
Dr. Cai Qichun is Director and academic leader of the Oncology Center at Guangdong Clifford Hospital, a chief physician and oncology PhD who trained at Sun Yat-sen University Cancer Center and formerly worked at the oncology center of Guangdong Provincial People's Hospital. She specializes in chemotherapy, targeted therapy and immunotherapy for malignant lymphoma, head and neck tumors, lung cancer, gastrointestinal tumors and gynecological cancers, with particular expertise in NK/T-cell lymphoma. She proposed a holistic tumor immunotherapy theory and has published more than 40 papers, including research in Nature Medicine. Her work on NK/T-cell lymphoma is internationally recognized, and she helped bring the first innovative lymphoma drug to Guangdong under the Hong Kong-Macao drug access program.
1、Director and academic leader of the Oncology Center at Guangdong Clifford Hospital; chief physician and oncology PhD
2、Trained at Sun Yat-sen University Cancer Center; formerly worked at the oncology center of Guangdong Provincial People’s Hospital before joining Clifford Hospital in 2018
3、Proposed a holistic tumor immunotherapy theory in 2002
4、Published more than 40 papers, including research in Nature Medicine, with NK/T-cell lymphoma research at an internationally advanced level
5、Deputy Secretary-General of the China Breast Disease Prevention and Treatment Committee
6、Helped bring the first innovative lymphoma drug to Guangdong under the Hong Kong-Macao drug access program
Dr. Cai Qichun ’s Three Key Areas of Expertise
Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.
Malignant lymphoma
Chemotherapy, targeted therapy and immunotherapy for malignant lymphoma; her research on NK/T-cell lymphoma, published in Nature Medicine, revealed how a gene mutation triggers severe inflammation and informs precision treatment for this aggressive disease, guiding individualized immunotherapy and improving patient outcomes.
Head and neck and lung cancer
Integrated chemo-immunotherapy; she designs individualized regimens combining chemotherapy, targeted therapy and immunotherapy to improve outcomes for patients with advanced head and neck and lung tumors, based on her holistic tumor immunotherapy theory and experience from multiple international clinical drug trials.
Gastrointestinal and gynecological tumors
Comprehensive precision oncology; she provides whole-course management from diagnosis to chemotherapy, targeted therapy and immunotherapy, and helped introduce an innovative lymphoma drug to Guangdong under the Hong Kong-Macao drug access program, improving access for local patients and offering clinical trial options.
More: difficult and refractory tumors, tumor immunotherapy, and clinical trials of novel anticancer drugs
Selected cases, research & publications
Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. CAR-T cell therapy for relapsed diffuse large B-cell lymphoma
A 32-year-old man with diffuse large B-cell lymphoma relapsed after nine prior lines of therapy, including autologous stem cell transplantation. Under the tumor center’s multidisciplinary team, he received axicabtagene ciloleucel CAR-T therapy; PET-CT one and three months later showed complete response, with no recurrence for over six months.
Related link: https://www.familydoctor.cn/yyzx/a/202506/3560433.html
2. Multidisciplinary management of refractory lymphoma
A specialized lymphoma team reviewed difficult cases including stage IV NK/T-cell lymphoma complicated by aortitis and coronary artery disease, and relapse after CAR-T therapy. Through guideline-based discussion and bedside rounds, the experts refined individualized treatment strategies for these hard-to-treat lymphoma patients, improving their chance of durable tumor control.
3. Serum interleukin-6 and prognosis of NK/T-cell lymphoma
This clinical study analyzed serum interleukin-6 levels in patients with NK/T-cell lymphoma and their relationship with treatment response and prognosis. It explored how the tumor microenvironment and inflammatory cytokines influence disease progression and help guide immunotherapy decisions for this aggressive, Epstein-Barr-virus-associated lymphoma subtype.
4. Holistic tumor immunotherapy theory
In a dedicated academic lecture, the specialist introduced the concept of holistic tumor immunotherapy, which coordinates immune checkpoint inhibitors, cellular therapy, and host immune reconstitution. The talk reviewed clinical cases showing how combining modalities can restore antitumor immunity and improve outcomes for patients with advanced or refractory malignancies.
Related link: https://www.163.com/dy/article/L6PF5P090511D05M.html
5. Precision oncology with integrated Chinese medicine
The tumor center integrates precision oncology with traditional Chinese medicine and natural therapies. Its five inpatient wards cover immunotherapy, thoracic tumors, hospice care, comprehensive treatment, and radiotherapy, supported by a clinical research laboratory, delivering whole-course management from active antitumor therapy to palliative and end-of-life care.
6. Clinical outcomes of NK/T-cell lymphoma
This retrospective clinical analysis reviewed patients with NK/T-cell lymphoma treated at a cancer center, summarizing clinicopathological features, treatment regimens, and survival outcomes. It identified prognostic factors that help clinicians select risk-adapted chemotherapy and radiotherapy strategies for this Epstein-Barr-virus-associated lymphoma, informing individualized treatment.
Where Dr. Cai Qichun practices
Guangdong Clifford Hospital
Chinese name: 广东祈福医院
Guangdong Clifford Hospital, founded in 2001 by Dr. Phylip Wei, is the first private hospital in China to pass international JCI accreditation and a large Grade-A tertiary hospital integrating Western, traditional Chinese and naturopathic medicine, offering 3,000 beds and patients from over 180 countries and territories.
Since 2001
25 years of care
3,000
Licensed beds
7 consecutive cycles
JCI accreditation
Designated provider
Licensed beds
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
Why patients travel to China for treatment
Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.
Clinical capability at international standard
Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.
Diagnostics and treatment in days, not months
A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.
Transparent, itemised pricing
Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.
Policy channels that open the door
China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
Consulting this physician, step by step
From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
- Share your storyA private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
- Records review & matchingOrisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
- Your consultationAppointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
- Reports & follow-upTranslated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.
Ready to plan your consultation with Dr. Cai Qichun?
Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Information Sources
This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.
- Clifford Hospital Official Profile: https://www.clifford-hospital.org.cn/expert/doctor_3396.html
- Guangdong Provincial People’s Hospital Doctor Page: https://m.youlai.cn/super/doctorinfo/50810/
Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.
Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Cai Qichun.